Epigenetic Changes and Potential Targets in Pancreatic Cancer

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-319-24951-3_2
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Cancer statistics, 2015

  2015cited by this paper
• Road to early detection of pancreatic cancer: Attempts to utilize epigenetic biomarkers.

  2014cited by this paper
• SOX15 is a candidate tumor suppressor in pancreatic cancer with a potential role in Wnt/β-catenin signaling

  2014cited by this paper
• ARID1B, a member of the human SWI/SNF chromatin remodeling complex, exhibits tumour-suppressor activities in pancreatic cancer cell lines

  2013cited by this paper
• MicroRNAs as diagnostic markers for pancreatic ductal adenocarcinoma and its precursor, pancreatic intraepithelial neoplasm.

  2013cited by this paper
• EZH2 Is Required for Breast and Pancreatic Cancer Stem Cell Maintenance and Can Be Used as a Functional Cancer Stem Cell Reporter

  2013cited by this paper
• Cationic microRNA-delivering nanovectors with bifunctional peptides for efficient treatment of PANC-1 xenograft model.

  2013cited by this paper
• miR-210 regulates the interaction between pancreatic cancer cells and stellate cells.

  2013cited by this paper
• Prospects of miRNA-based therapy for pancreatic cancer.

  2013cited by this paper
• Somatic Mutations in Exocrine Pancreatic Tumors: Association with Patient Survival

  2013cited by this paper
• miR-143 decreases COX-2 mRNA stability and expression in pancreatic cancer cells.

  2013cited by this paper
• miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1

  2013cited by this paper
• Insights into the epigenetic mechanisms controlling pancreatic carcinogenesis.

  2013cited by this paper
• miR‐197 induces epithelial–mesenchymal transition in pancreatic cancer cells by targeting p120 catenin

  2013cited by this paper
• NPTX2 Hypermethylation in Pure Pancreatic Juice Predicts Pancreatic Neoplasms

  2013cited by this paper
• Clinical impact of circulating miR-221 in plasma of patients with pancreatic cancer

  2013cited by this paper
• MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3.

  2013cited by this paper
• Association of vascular endothelial growth factor (VEGF) gene polymorphism and increased serum VEGF concentration with pancreatic adenocarcinoma.

  2013cited by this paper
• Cancer detection by ubiquitin carboxyl-terminal esterase L1 methylation in pancreatobiliary fluids.

  2013cited by this paper
• Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer

  2013cited by this paper
• DNA methyltransferase inhibitors and their emerging role in epigenetic therapy of cancer.

  2013cited by this paper
• Cancer specific promoter CpG Islands hypermethylation of HOP homeobox (HOPX) gene and its potential tumor suppressive role in pancreatic carcinogenesis

  2012cited by this paper
• The Role of Quantitative NPTX2 Hypermethylation as a Novel Serum Diagnostic Marker in Pancreatic Cancer

  2012cited by this paper
• Molecular Mechanisms Involved in the Synergistic Interaction of the EZH2 Inhibitor 3-Deazaneplanocin A with Gemcitabine in Pancreatic Cancer Cells

  2012cited by this paper
• miR‐301a promotes pancreatic cancer cell proliferation by directly inhibiting bim expression

  2012cited by this paper
• miR-148b Functions as a Tumor Suppressor in Pancreatic Cancer by Targeting AMPKα1

  2012cited by this paper
• MicroRNA-10a is Overexpressed in Human Pancreatic Cancer and Involved in Its Invasiveness Partially via Suppression of the HOXA1 Gene

  2012cited by this paper
• MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro.

  2012cited by this paper
• 3‐Deazaneplanocin A is a promising therapeutic agent for the eradication of tumor‐initiating hepatocellular carcinoma cells

  2012cited by this paper
• miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway

  2012cited by this paper
• Neuronal pentraxin II (NPTX2) Is Frequently Down-Regulated by Promoter Hypermethylation in Pancreatic Cancers

  2012cited by this paper
• CXCL12/CXCR4 axis plays pivotal roles in the organ-specific metastasis of pancreatic adenocarcinoma: A clinical study

  2012cited by this paper
• MicroRNA miR-491-5p Targeting both TP53 and Bcl-XL Induces Cell Apoptosis in SW1990 Pancreatic Cancer Cells through Mitochondria Mediated Pathway

  2012cited by this paper
• Metformin alters the expression profiles of microRNAs in human pancreatic cancer cells.

  2012cited by this paper
• Genistein inhibits cell growth and induces apoptosis through up-regulation of miR-34a in pancreatic cancer cells.

  2012cited by this paper
• Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer.

  2012cited by this paper
• Clinical implications of mismatched repair gene promoter methylation in pancreatic cancer

  2012cited by this paper
• Krüppel-like factor 10 expression as a prognostic indicator for pancreatic adenocarcinoma.

  2012cited by this paper
• The neuronal pentraxin II gene (NPTX2) inhibit proliferation and invasion of pancreatic cancer cells in vitro

  2011cited by this paper
• MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells.

  2011cited by this paper
• Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer

  2011cited by this paper
• Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?

  2011cited by this paper
• Targeting Epigenetic Regulation of miR-34a for Treatment of Pancreatic Cancer by Inhibition of Pancreatic Cancer Stem Cells

  2011cited by this paper
• Altered Telomeres in Tumors with ATRX and DAXX Mutations

  2011cited by this paper
• The increase in the expression and hypomethylation of MUC4 gene with the progression of pancreatic ductal adenocarcinoma

  2011cited by this paper
• Dickkopf3 overexpression inhibits pancreatic cancer cell growth in vitro.

  2011cited by this paper
• EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling.

  2011cited by this paper
• Transcriptional regulation of claudin‐18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells

  2011cited by this paper
• EZH2-mediated epigenetic repression of DNA repair in promoting breast tumor initiating cells

  2011cited by this paper
• miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor.

  2011cited by this paper
• Genome-Wide CpG Island Profiling of Intraductal Papillary Mucinous Neoplasms of the Pancreas

  2011cited by this paper
• MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B

  2011cited by this paper
• Pancreatic cancer stem cells: new insights and perspectives

  2011cited by this paper
• Detection of Differentially Expressed microRNAs in Serum of Pancreatic Ductal Adenocarcinoma Patients: miR-196a Could Be a Potential Marker for Poor Prognosis

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer.

  2011cited by this paper
• Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer

  2011cited by this paper
• Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas

  2011cited by this paper
• Ovarian Cancer Stem Cell–Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2

  2011cited by this paper
• Aberrant methylation frequency of TNFRSF10C promoter in pancreatic cancer cell lines.

  2011cited by this paper
• A decade of exploring the cancer epigenome — biological and translational implications

  2011cited by this paper
• Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development.

  2011cited by this paper
• Cancer stem cells: problems for therapy?

  2011cited by this paper
• MicroRNAs in pancreatic ductal adenocarcinoma.

  2011cited by this paper
• MicroRNA 421 suppresses DPC4/Smad4 in pancreatic cancer.

  2011cited by this paper
• Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study

  2011cited by this paper
• MiR-126 Acts as a Tumor Suppressor in Pancreatic Cancer Cells via the Regulation of ADAM9

  2011cited by this paper
• Cancer statistics, 2011

  2011cited by this paper
• Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer

  2010cited by this paper
• Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

  2010cited by this paper
• Targeting Hedgehog — a Cancer Stem Cell Pathway

  2010cited by this paper
• Development of curcumin as an epigenetic agent

  2010cited by this paper
• Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras.

  2010cited by this paper
• Deacetylase inhibitors - focus on non-histone targets and effects.

  2010cited by this paper
• EP300—A miRNA‐regulated metastasis suppressor gene in ductal adenocarcinomas of the pancreas

  2010cited by this paper
• Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205.

  2010cited by this paper
• Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.

  2010cited by this paper
• Pancreatic cancer DNMT1 expression and sensitivity to DNMT1 inhibitors

  2010cited by this paper
• Epigenetic Regulation Affects N-myc Downstream-Regulated Gene 1 Expression Indirectly in Pancreatic Cancer Cells

  2010cited by this paper
• Human DNA methylomes at base resolution show widespread epigenomic differences

  2009cited by this paper
• Identification of human pancreatic cancer stem cells.

  2009cited by this paper
• Epigenetic Silencing of MicroRNA miR-107 Regulates Cyclin-Dependent Kinase 6 Expression in Pancreatic Cancer

  2009cited by this paper
• Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer.

  2009cited by this paper
• let-7 MicroRNA Transfer in Pancreatic Cancer-Derived Cells Inhibits In Vitro Cell Proliferation but Fails to Alter Tumor Progression

  2009cited by this paper
• MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease

  2009cited by this paper
• Antisense Inhibition of microRNA-21 or -221 Arrests Cell Cycle, Induces Apoptosis, and Sensitizes the Effects of Gemcitabine in Pancreatic Adenocarcinoma

  2009cited by this paper
• Combined targeting of histone deacetylases and hedgehog signaling enhances cytoxicity in pancreatic cancer

  2009cited by this paper
• Epigenetic changes in cancer.

  2009cited by this paper
• Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

  2009cited by this paper
• Profiling of 95 MicroRNAs in Pancreatic Cancer Cell Lines and Surgical Specimens by Real-Time PCR Analysis

  2009cited by this paper
• Involvement of CD40 Targeting miR-224 and miR-486 on the Progression of Pancreatic Ductal Adenocarcinomas

  2009cited by this paper
• Chromatin signatures in multipotent human hematopoietic stem cells indicate the fate of bivalent genes during differentiation.

  2009cited by this paper
• MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance

  2009cited by this paper
• MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-Initiating Cells

  2009cited by this paper
• Epigenetics and epigenetic alterations in pancreatic cancer.

  2009cited by this paper
• Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice

  2008cited by this paper
• Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

  2008cited by this paper
• High Histone Deacetylase 7 (HDAC7) Expression Is Significantly Associated with Adenocarcinomas of the Pancreas

  2008cited by this paper
• ICF, An Immunodeficiency Syndrome: DNA Methyltransferase 3B Involvement, Chromosome Anomalies, and Gene Dysregulation

  2008cited by this paper
• Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts.

  2008cited by this paper

• No citing papers are available for this paper.